Predictors of duration of abiraterone acetate in men with castration resistant prostate cancer

BACKGROUND: Androgen receptor signaling remains important in castration resistant prostate cancer (CRPC) as demonstrated by the efficacy of abiraterone acetate (henceforth abiraterone) in phase III trials. Given that heterogeneous patient responses are observed, we sought to determine clinical facto...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Prostate Cancer Prostatic Dis
Asıl Yazarlar: McKay, Rana R., Werner, Lillian, Fiorillo, Matthew, Nakabayashi, Mari, Kantoff, Philip W., Taplin, Mary-Ellen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034654/
https://ncbi.nlm.nih.gov/pubmed/27502737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.31
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller